More than 20 years of experience

20
02
04
06
12
15
17
18
19
22
23

2002

Sun Asia International Trading (NFTZ) Co. Ltd. was established on May 29, 2002 in Ningbo Free Trade Zone, China, supplying quality-certified made-in-China ingredients to the global pharmaceutical industry.

2004

Established long-term partnerships with global pharmaceutical companies such as Daiichi Sankyo, and exclusively supply customized intermediates.

2006

With China's preferential foreign trade policy, Sunasia Co., Ltd. was formally established on January 6, 2006, and continued the same business.

2012

One of our main products - nucleotides for infant formula are exported to Europe, America and other international markets.

2015

Started to participate in many international biddings, and won with high quality, low price and excellent service, which gained a good reputation for the company in the world.

2017

Sunasia (HK) Limited, our marketing subsidiary, was established in Hong Kong on February 14, 2017.

2018

Our advanced intermediates for psychotropic drugs were successfully developed and exported to South America in large quantities every year.

2019

Co-founded the first factory in Taizhou, Zhejiang, and started to provide contract manufacturing services for APIs and intermediates.

2022

By the end of 2022, our annual sales have exceeded 30 million US dollars, firmly ranking among the important members of Ningbo International Chamber of Commerce.

2023

Formed three business divisions. Contract Manufacturing, APIs and Pharmaceutical Intermediates, based on the core capabilities of the company. Set the stage for focused growth globally.

2002

Sun Asia International Trading (NFTZ) Co. Ltd. was established on May 29, 2002 in Ningbo Free Trade Zone, China, supplying quality-certified made-in-China ingredients to the global pharmaceutical industry.

2004

Established long-term partnerships with global pharmaceutical companies such as Daiichi Sankyo, and exclusively supply customized intermediates.

2006

With China's preferential foreign trade policy, Sunasia Co., Ltd. was formally established on January 6, 2006, and continued the same business.

2012

One of our main products - nucleotides for infant formula are exported to Europe, America and other international markets.

2015

Started to participate in many international biddings, and won with high quality, low price and excellent service, which gained a good reputation for the company in the world.

2017

Sunasia (HK) Limited, our marketing subsidiary, was established in Hong Kong on February 14, 2017.

2018

Our advanced intermediates for psychotropic drugs were successfully developed and exported to South America in large quantities every year.

2019

Co-founded the first factory in Taizhou, Zhejiang, and started to provide contract manufacturing services for APIs and intermediates.

2022

By the end of 2022, our annual sales have exceeded 30 million US dollars, firmly ranking among the important members of Ningbo International Chamber of Commerce.

2023

Formed three business divisions. Contract Manufacturing, APIs and Pharmaceutical Intermediates, based on the core capabilities of the company. Set the stage for focused growth globally.